Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway.

Manjunath Amit P PaiPier Giorgio CojuttiValentina GerussiPaola Della SiegaCarlo TasciniFederico Pea

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Lower empiric linezolid doses in cardiosurgical patients may avoid toxicities. Confirmatory studies are necessary to verify these potential drug interactions.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
risk assessment
staphylococcus aureus